HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion (Q40513465)

21 September 2017

HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion (English)

1 reference

21 September 2017

1 reference

4

1 reference

21 September 2017

Marielle Cavrois

1

1 reference

21 September 2017

Jason Neidleman

series ordinal

2

1 reference

21 September 2017

Wes Yonemoto

series ordinal

3

1 reference

21 September 2017

Warner C Greene

series ordinal

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

21 September 2017

1 reference

21 September 2017

328

1 reference

21 September 2017

36-44

1 reference

21 September 2017

1

1 reference

Nef: agent of cell subversion

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Disassembly of human immunodeficiency virus type 1 cores in vitro reveals association of Nef with the subviral ribonucleoprotein complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Specific incorporation of cyclophilin A into HIV-1 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Generation of human monoclonal antibodies to human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Infectivity enhancement by HIV-1 Nef is dependent on the pathway of virus entry: implications for HIV-based gene transfer systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

The Nef protein of primate lentiviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Sterols and sphingolipids strongly affect the growth of fusion pores induced by the hemagglutinin of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Requirement of nef for HIV-1 infectivity is biased by the expression levels of Env in the virus-producing cells and CD4 in the target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Nef increases infectivity of HIV via lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

7 January 2021

Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

7 January 2021

Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

7 January 2021

Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

7 January 2021

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.07.015

7 January 2021

10.1016/J.VIROL.2004.07.015

Identifiers

DOI

1 reference

21 September 2017

1 reference